Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Regulatory News (IXI)

Share Price Information for Ixico (IXI)

Share Price is delayed by 15 minutes
Get Live Data
8.65    0.00 (0.00%)
Bid:
8.30
Ask:
9.00
Spread: 0.70 (8.434%)
Market Cap: £18.86m
IXI Live PriceLast checked at - London Stock Exchange

Intraday Ixico Share Chart

Annual Information Update

7 Feb 2011 12:18

RNS Number : 7974A
Phytopharm PLC
07 February 2011
 

Phytopharm plc

 

Annual Information Update

 

Phytopharm plc (the Company) announces that, in accordance with the requirements of Prospectus Rule 5.2 issued by the Financial Services Authority, and following publication of the Annual Report on 31 January 2011, the following information has been published or made available to the public between 14 December 2009 and 7 February 2011 inclusive, in compliance with laws and rules dealing with the regulation of securities, issuers of securities and securities markets.

1. Announcements made via the Regulatory Information Service ("RIS")

All the announcements listed below were published through a regulatory information service on the dates indicated. Copies can be obtained from the London Stock Exchange website, http://www.londonstockexchange.com or from the Company's website www.phytopharm.com

Date of publication

Title

1 February 2011

Total voting rights

1 February 2011

Annual Report 2010 and notice of 2011 AGM

19 January 2011

Director/PDMR shareholding

19 January 2011

Director/PDMR shareholding

14 January 2011

Holdings in Company

10 January 2011

Holdings in Company

7 January 2011

Block Listing Application

4 January 2011

Total voting rights

21 December 2010

Director/PDMR shareholding

21 December 2010

Director/PDMR shareholding

14 December 2010

Block Listing application

30 November 2010

Final results

17 November 2010

Research update

3 November 2010

Block listing interim review

1 November 2010

Preliminary results - change of date

1 November 2010

Notice of preliminary results

29 September 2010

Presentation at scientific conference

18 August 2010

Interim management statement

22 July 2010

Director/PDMR shareholding

22 July 2010

Director/PDMR shareholding

5 July 2010

Change of registered office

21 June 2010

Appointment of Chief Executive Officer

14 June 2010

Regulatory approval to begin Cogane™ Phase II trial

24 May 2010

Half yearly report

19 May 2010

Notice of results

4 May 2010

Block listing interim review

1 April 2010

Director/PDMR shareholding

1 April 2010

Director/PDMR shareholding

1 April 2010

Director/PDMR shareholding

31 March 2010

Results of Annual General Meeting

2 March 2010

Notice of Annual General Meeting

11 February 2010

Interim Management Statement

15 January 2010

Appointment of R & D Director

5 January 2010

Holding in company

4 January 2010

Total voting rights

31 December 2009

Director/PDMR shareholding

31 December 2009

Director/PDMR shareholding

31 December 2009

Director/PDMR shareholding

31 December 2009

Director/PDMR shareholding

29 December 2009

GM results

22 December 2009

Open Offer results

15 December 2009

Correction to Form of Proxy

15 December 2009

Annual Information update

14 December 2009

Presents data at XVIII WFN Congress

2. Documents published or sent to Shareholders, filed with the UK Listing Authority or submitted to the FSA including those filed with the National Storage Mechanism:

Date of publication

Title

1 February 2011

Notice of 2011 Annual General Meeting

1 February 2011

Annual Report 2010

2 June 2010

Interim Report 2010

31 March 2010

AGM resolutions

2 March2010

Notice of Annual General Meeting

30 December 2009

General Meeting resolutions

The 2010 Interim and 2010 Annual reports are available on the Company's website www.phytopharm.com

3. Documents filed at Companies House

The following documents were files at Companies House. Copies of these documents can be obtained from the Companies House website at www.companieshouse.gov.uk, or Companies House, Crown Way, Cardiff CF14 3UZ

Date of Publication

Title

25 January 2011

Form SH01 Return of allotment of shares on 14 January 2011

5 January 2011

Form SH01 Return of allotment of shares on 16 December 2010

16 December 2010

Form AR01 Annual return

6 July 2010

Form AP01 Appointment of director

6 July 2010

Form AD01 change of registered office address

31 March 2010

Articles of Association approved by shareholders on 30 march 2010

31 March 2010

Annual General Meeting resolutions

25 January 2010

Form AP01 Appointment of director

4 January 2010

Form SH01 Return of allotment of shares on 29 December 2009

Copies of all documents referred to above are also available for inspection at the Company's registered office (Lakeview House, 2 Lakeview Court, Ermine Business Park, Huntingdon, Cambs PE29 6UA, United Kingdom) during normal business hours or by written request from the Company Secretary.

This annual information is required by, and is being made pursuant to, Article 10 of the Prospectus Directive as implemented by the UK Prospectus Rule 5.2 and not for any other purpose and neither the Company, nor any other person, takes any responsibility for, or makes any representation, express of implied, as to the accuracy or completeness of, the information which it contains. The information is not necessarily up to date as at the date of this annual information update and the Company does not undertake any obligation to update any such information in the future. Neither this annual information update, not referred to in it, constitutes, by virtue of this communication, an offer of securities addressed to any person and it should not be relied on by any person.

For further information, please contact:

Zoe McGowan, Company Secretary

Phytopharm plc Tel No: +44 (0)1480 437697

Further information about Phytopharm can be found on the Company's website www.phytopharm.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AIUEAAAXEFAFEFF
Date   Source Headline
26th Aug 202011:55 amRNSInvestor presentation
24th Aug 20209:05 amRNSSecond Price Monitoring Extn
24th Aug 20209:00 amRNSPrice Monitoring Extension
24th Aug 20207:00 amRNSTrading Update
13th Aug 20207:00 amRNSInvestor Presentation
8th Jul 20207:00 amRNSConference attendance - On Helix Digital
6th Jul 20207:00 amRNSGrant of share options
24th Jun 20207:00 amRNSTrading Update
20th May 20207:00 amRNSHalf yearly report to 31 March 2020
12th May 20207:00 amRNSNotice of Results
20th Apr 20207:00 amRNSTrading update for H1 2020
14th Apr 20207:00 amRNS£10.5m contract win, update on trading & COVID-19
16th Mar 20209:00 amRNSIXICO announces expanded contract with Vaccinex
2nd Mar 202011:05 amRNSSecond Price Monitoring Extn
2nd Mar 202011:00 amRNSPrice Monitoring Extension
26th Feb 202011:05 amRNSSecond Price Monitoring Extn
26th Feb 202011:00 amRNSPrice Monitoring Extension
19th Feb 20209:00 amRNSIXICO to Present AI Segmentation Research
17th Feb 20204:40 pmRNSSecond Price Monitoring Extn
17th Feb 20204:35 pmRNSPrice Monitoring Extension
17th Feb 20202:05 pmRNSSecond Price Monitoring Extn
17th Feb 20202:00 pmRNSPrice Monitoring Extension
11th Feb 20207:00 amRNSHolding(s) in Company
10th Feb 20209:11 amRNSIXICO to Present at Innovation Forum
3rd Feb 20209:00 amRNSIXICO Supports the AD Neuroimaging Initiative
23rd Jan 20207:00 amRNSDirector/PDMR Shareholding
17th Jan 20204:34 pmRNSResult of AGM
15th Jan 202010:32 amRNSDirector/PDMR Shareholding
13th Jan 20201:29 pmRNSIssue of Equity
23rd Dec 20197:00 amRNSIXICO announces updates to client contracts
20th Dec 20197:00 amRNSStatement re Annual Report and Notice of AGM
9th Dec 20199:26 amRNSPDMR share sale
9th Dec 20197:02 amRNSHolding(s) in Company
9th Dec 20197:00 amRNSPDMR share purchase
5th Dec 20198:22 amRNSDirector/PDMR Shareholding
4th Dec 20197:00 amRNSFinancial Results for the year ended 30 Sept 2019
2nd Dec 20197:00 amRNSIXICO to Present at Alzheimer's Disease Congress
22nd Nov 20197:00 amRNSNotice of Results
5th Nov 20199:00 amRNSIXICO to Present at HD and Ataxia Conferences
4th Nov 20192:51 pmRNSHolding(s) in Company
30th Oct 20199:00 amRNSIXICO to Present at 10th Annual CNS Summit 2019
28th Oct 20197:00 amRNSIXICO announces client contracts and appointed CBO
18th Oct 20197:00 amRNSHolding(s) in Company
15th Oct 20197:00 amRNSTrading Update for year ended 30 September 2019
11th Sep 20197:00 amRNSDirector/PDMR Shareholding
9th Sep 201911:48 amRNSHolding(s) in Company
9th Sep 201911:46 amRNSHolding(s) in Company
5th Sep 20193:43 pmRNSHolding(s) in Company
4th Sep 20195:07 pmRNSHolding(s) in Company
28th Aug 201912:21 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.